This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Raivio, T L Articles by Storey, D G Search for Related Content PubMed PubMed Citation Articles by Raivio, T L Articles by Storey, D G

 Previous Article  |  Next Article 

Infection and Immunity, August 1994, p. 3506-3514, Vol. 62, No. 8
0019-9567/1994/$04.00+0     DOI:

research-article

Association between transcript levels of the Pseudomonas aeruginosa regA, regB, and toxA genes in sputa of cystic fibrosis patients.

Department of Microbiology and Infectious Diseases, University of Calgary, Alberta, Canada.

ABSTRACT

In this study, we examined the regulation of exotoxin A (ETA) production by Pseudomonas aeruginosa during chronic lung infections of cystic fibrosis (CF) patients. We used a recently developed technique termed population transcript accumulation in hybridization studies with RNA extracted from sputa. With this technique, we demonstrated that the structural gene for ETA, toxA, as well as two genes encoding positive regulators of ETA synthesis, regA and regB, were expressed in the lungs of CF patients infected with P. aeruginosa. These genes were always expressed together, never alone or in pairs, suggesting coincident expression and a possible regulatory role for regA and regB in this environment. Fluctuations in the levels of the three gene products were observed among samples, consistent with a regulatory phenomenon. The level of regB RNA detected never exceeded that of regA, although the ratio of regA RNA to regB RNA detected did change between samples. These observations are in agreement with in vitro observations which have shown that regB is located 3' to regA in an operon which is expressed from two independently regulated promoters located upstream of regA. The presence of high levels of toxA, regA, and regB RNAs in some sputum samples prompted us to look for hyperproducing-toxin strains in the sputa of CF patients. In vitro, one such strain, 4384, had a transcript accumulation pattern for toxA, regA, and regB similar to that of a laboratory hyperproducer of ETA, strain PA103. These observations suggest that regA and regB are involved in the regulation of ETA production in strains of P. aeruginosa infecting the lungs of CF patients and that some of these strains may regulate ETA production in a manner similar to that of the hyperproducing-ETA strain PA103.

This article has been cited by other articles:

• Lutter, E. I., Faria, M. M. P., Rabin, H. R., Storey, D. G. (2008). Pseudomonas aeruginosa Cystic Fibrosis Isolates from Individual Patients Demonstrate a Range of Levels of Lethality in Two Drosophila melanogaster Infection Models. Infect. Immun. 76: 1877-1888 [Abstract] [Full Text]  
• Gaines, J. M., Carty, N. L., Colmer-Hamood, J. A., Hamood, A. N. (2005). Effect of static growth and different levels of environmental oxygen on toxA and ptxR expression in the Pseudomonas aeruginosa strain PAO1. Microbiology 151: 2263-2275 [Abstract] [Full Text]  
• Hunt, T. A., Peng, W.-T., Loubens, I., Storey, D. G. (2002). The Pseudomonas aeruginosa alternative sigma factor PvdS controls exotoxin A expression and is expressed in lung infections associated with cystic fibrosis. Microbiology 148: 3183-3193 [Abstract] [Full Text]  
• Gallant, C. V., Raivio, T. L., Olson, J. C., Woods, D. E., Storey, D. G. (2000). Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity. Microbiology 146: 1891-1899 [Abstract] [Full Text]  
• Storey, D. G., Ujack, E. E., Rabin, H. R., Mitchell, I. (1998). Pseudomonas aeruginosa lasR Transcription Correlates with the Transcription of lasA, lasB, and toxA in Chronic Lung Infections Associated with Cystic Fibrosis. Infect. Immun. 66: 2521-2528 [Abstract] [Full Text]